RIGL relationship map
RIGL
Rigel Pharmaceuticals Inc
Ataraunlisted—
Blueprint Medicines Corporation, now a Sanofi SA company (Blueprint)unlisted—
Collaborative Network for Neuro-Oncology Clinical Trials (CONNECT)unlisted—
Formaunlisted—
University of Texas MD Anderson Cancer Center (MDACC)unlisted—
← Buys from
RIGLRigel Pharmaceuticals Inc
—McKessonunlisted
42.00% of RIGL sales10-K
—Cencoraunlisted
19.00% of RIGL sales10-K
—BerGenBiounlisted
—Biomedical Advanced Research and Development (BARDA)unlisted
—Cardinal Healthunlisted
—Daiichiunlisted
—Grifolsunlisted
—Kisseiunlisted
—Knightunlisted
—Lillyunlisted
—Medisonunlisted
—US Department of Defense (DOD)unlisted
Sells to →
Suppliers6Customers13
Ataraunlisted
Blueprint Medicines Corporation, now a Sanofi SA company (Blueprint)unlisted
Collaborative Network for Neuro-Oncology Clinical Trials (CONNECT)unlisted
Formaunlisted
University of Texas MD Anderson Cancer Center (MDACC)unlisted
RIGL
suppliercustomerunlisted2°second-degree (Extended)
Thick line = filed share ·Moves · 11:00 ETSources